Cysteine scanning of transmembrane domain three of the human dipeptide transporter: Implications for substrate transport

Journal of Drug Targeting

Volumn 15, Issue 3, 2007, Pages 218-225

  Links, Jennifer L S ^a   Kulkarni, Ashutosh A ^a   Davies, Daryl L ^a   Lee, Vincent H L ^a   Haworth, Ian S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cysteine scanning; MTS; Mutagenesis; PepT1; Protein structure; Transporter

Indexed keywords

CARRIER PROTEIN; CYSTEINE; DIPEPTIDE TRANSPORTER 1; METHANE THIOSULFONATE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CYSTEINE SCANNING MUTAGENESIS; DRUG TRANSPORT; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SITE DIRECTED MUTAGENESIS; STATISTICAL SIGNIFICANCE; WILD TYPE;

BASE SEQUENCE; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CYSTEINE; DIPEPTIDES; ETHYL METHANESULFONATE; HUMANS; MESYLATES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POINT MUTATION; SUBSTRATE SPECIFICITY; SYMPORTERS; TRANSFECTION;

EID: 34147099014     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860701267491     Document Type: Article

References (32)

1. Bailey, PD, Boyd, CA, Bronk, JR, Collier, ID, Meredith, D., Morgan, KM and Temple, CS (2000) How to make drugs orally active: A substrate template for peptide transporter PepT1. Angew Chem Int Ed Engl, 39, pp. 505-508.
2. Balimane, PV, Tamai, I., Guo, A., Nakanishi, T., Kitada, H., Leibach, FH, Tsuji, A. and Sinko, PJ (1998) Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. Biochem Biophys Res Commun, 250, pp. 246-251.
3. Biegel, A., Gebauer, S., Hartrodt, B., Brandsch, M., Neubert, K. and Thondorf, I. (2005) Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1. J Med Chem, 48, pp. 4410-4419.
4. Bolger, MB, Haworth, IS, Yeung, AK, Ann, D., von Grafenstein, H., Hamm-Alvarez, S., Okamoto, CT, Kim, KJ, Basu, SK and Lee, VHL (1998) Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1. J Pharm Sci, 87, pp. 1286-1291.
5. Brandsch, M., Knutter, I. and Leibach, FH (2004) The intestinal H+/ peptide symporter PEPT1: Structure-affinity relationships. Eur J Pharm Sci, 21, pp. 53-60.
6. Daniel, H. (2004) Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol, 66, pp. 361-384.
7. Doring, F., Will, J., Amasheh, S., Clauss, W., Ahlbrecht, H. and Daniel, H. (1998) Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter. J Biol Chem, 273, pp. 23211-23218.
8. Fei, YJ, Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, FH, Romero, MF, Singh, SK, Boron, WF and Hediger, MA (1994) Expression cloning of a mammalian proton-coupled oligopeptide transporter. Nature, 368, pp. 563-566.
9. Heinze, M., Monden, I. and Keller, K. (2004) Cysteine-scanning mutagenesis of transmembrane segment 1 of glucose transporter GLUT1: Extracellular accessibility of helix positions. Biochemistry, 43, pp. 931-936.
10. Hruzand, PW and Mueckler, M. (2000) Cysteine-scanning mutagenesis of transmembrane segment 11 of the GLUT1 facilitative glucose transporter. Biochemistry, 39, pp. 9367-9372.
11. Javitch, JA, Kaback, J. and Karlin, A. (1994) A cysteine residue in the third membrane-spanning segment of the human D2 dopamine receptor is exposed in the binding-site crevice. Proc Natl Acad Sci USA, 91, pp. 10355-10359.
12. Katsura, T. and Inui, K. (2003) Intestinal absorption of drugs mediated by drug transporters: Mechanisms and regulation. Drug Metab Pharmacokinet, 18, pp. 1-15.
13. Kulkarni, AA, Haworth, IS and Lee, VHL (2003) Transmembrane segment 5 of the dipeptide transporter hPepT1 forms a part of the substrate translocation pathway. Biochem Biophys Res Commun, 306, pp. 177-185.
14. Kulkarni, AA, Haworth, IS, Uchiyama, T. and Lee, VHL (2003) Analysis of transmembrane segment 7 of the dipeptide transporter hPepT1 by cysteine-scanning mutagenesis. J Biol Chem, 278, pp. 51833-51840.
15. Kulkarni, AA, Davies, DL, Links, JS, Patel, LN, Lee, VHL and Haworth, IS (2007) A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of the human dipeptide transporter hPepT1. Pharm Res, 24, pp. 66-72.
16. Landowski, CP, Vig, BS, Song, X. and Amidon, GL (2005) Targeted delivery to PEPT1-overexpressing cells: Acidic, basic, and secondary floxuridine amino acid ester prodrugs. Mol Cancer Ther, 4, pp. 659-667.
17. Liang, R., Fei, YJ, Prasad, PD, Ramamoorthy, S., Han, H., Yang-Feng, TL, Hediger, MA, Ganapathy, V. and Leibach, FH (1995) Human intestinal H+/ peptide cotransporter. Cloning, functional expression, and chromosomal localization. J Biol Chem, 270, pp. 6456-6463.
18. Lin, CJ, Akarawut, W. and Smith, DE (1999) Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: Interaction of ACE inhibitors with high-affinity H+/ peptide symporter. Pharm Res, 16, pp. 609-615.
19. Hong, L., Mau, CI, Chan, R., Hendricks, T., Dvorak, C., Yee, C., Harris, J. and Alfredson, T. (2006) Transport of levovirin prodrugs in the human intestinal Caco-2 cell line. J Pharm Sci, 95, pp. 1318-1325.
20. Miller, C. (1995) Silver as a probe of pore-forming residues in a potassium channel. Science, 268, pp. 304-307.
21. Luckner, P. and Brandsch, M. (2005) Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: Analysis of affinity constants and comparison with PEPT1. Eur J Pharm Biopharm, 59, pp. 17-24.
22. Mueckler, M. and Makepeace, C. (2005) Cysteine-scanning mutagenesis and substituted cysteine accessibility analysis of transmembrane segment 4 of the Glut1 glucose transporter. J Biol Chem, 280, pp. 39562-39568.
23. Perez-Garcia, MT, Chiamvimonvat, N., Marban, E. and Tomaselli, GF (1996) Structure of the sodium channel pore revealed by serial cysteine mutagenesis. Proc Natl Acad Sci USA, 93, pp. 300-304.
24. Sahin-Toth, M. and Kaback, HR (1993) Cysteine scanning mutagenesis of putative transmembrane helices IX and X in the lactose permease of Escherichia coli. Protein Sci, 2, pp. 1024-1033.
25. Song, X., Lorenzi, PL, Landowski, CP, Vig, BS, Hilfinger, JM and Amidon, GL (2005) Amino acid ester prodrugs of the anticancer agent gemcitabine: Synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport. Mol Pharm, 2, pp. 157-167.
26. Steffansen, B., Nielsen, CU and Frokjaer, S. (2005) Delivery aspects of small peptides and substrates for peptide transporters. Eur J Pharm Biopharm, 60, pp. 241-245.
27. Temple, CS and Boyd, CA (1998) Proton-coupled oligopeptide transport by rat renal cortical brush border membrane vesicles: A functional analysis using ACE inhibitors to determine the isoform of the transporter. Biochim Biophys Acta, 1373, pp. 277-281.
28. Terada, T. and Inui, K. (2004) Peptide transporters: Structure, function, regulation and application for drug delivery. Curr Drug Metab, 5, pp. 85-94.
29. Thomsen, AE, Christensen, MS, Bagger, MA and Steffansen, B. (2004) Acyclovir prodrug for the intestinal di/tri-peptide transporter PEPT1: Comparison of in vivo bioavailability in rats and transport in Caco-2 cells. Eur J Pharm Sci, 23, pp. 319-325.
30. Vig, BS, Stouch, TR, Timoszyk, JK, Quan, Y., Wall, DA, Smith, RL and Faria, TN (2006) Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding. J Med Chem, 49, pp. 3636-3644.
31. Yeung, AK, Basu, SK, Wu, SK, Chu, C., Okamoto, CT, Hamm-Alvarez, SF, von Grafenstein, H., Shen, WC, Kim, KJ, Bolger, MB, Haworth, IS, Ann, DK and Lee, VHL (1998) Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton-coupled dipeptide transporter (hPepT1). Biochem Biophys Res Commun, 250, pp. 103-107.
32. Zhu, T., Chen, XZ, Steel, A., Hediger, MA and Smith, DE (2000) Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2. Pharm Res, 17, pp. 526-532.